Principal results
T1D
EVENT
This pilot study of remote patient monitoring in a cohort of pediatric patients with T1D found that RPM was highly feasible and satisfactory for participants. Its findings also suggest RPM may be beneficial for glycemic management, particularly among participants with higher baseline glycemic levels (GMI ≥8%), who demonstrated a clinically and statistically significant GMI reduction over six months’ time. The fact that this subgroup’s glycemic improvement was achieved primarily It is notable that these results were achieved with relatively infrequent clinician contact (monthly or less) and a median time of only 10 minutes per outreach event. The amount of clinician time required per month (1.75-4.6 hours total or 2.9-7.6 minutes per participant) for RPM in this study suggests that such an intervention could be feasibly scaled to larger populations. However, we expect that such time estimates are highly sensitive to the population’s baseline glycemic control, the specific outreach criteria, and the chosen method(s) of outreach, so these factors should be considered when attempting to extrapolate from our study’s time estimates to another RPM program. Importantly, our survey results indicate that most RPM recipients preferred asynchronous outreach over telephone contact, and study data demonstrated that the former also required less provider time than the latter. However, the research team found the utility of EHR messaging limited in our cohort by a high frequency of inactive accounts and unread messages, suggesting that future RPM programs would benefit from use of mobile text messaging instead.